Clinical Trial Update: Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the off-target effects of linagliptin monotherapy on arterial stiffness in individuals with early Type 2 diabetes; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)
• Tradjenta (Linagliptin)

Snippet

Sponsor: dr. DJ Mulder | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED